Australia markets closed

    -150.10 (-1.95%)

    -0.0030 (-0.41%)
  • ASX 200

    -140.60 (-1.90%)
  • OIL

    -0.47 (-0.65%)
  • GOLD

    -0.90 (-0.05%)

    -3,706.92 (-5.54%)
  • CMC Crypto 200

    -81.96 (-6.69%)

Healthcare Contract Research Organization Market Size, Share & Trends Analysis Report By Type, By Service, By Region And Segment Forecasts, 2021 - 2028

·3-min read

Healthcare Contract Research Organization Market Size, Share & Trends Analysis Report By Type (Drug Discovery, Pre-clinical, Clinical), By Service (Clinical Monitoring, Data Management), By Region, And Segment Forecasts, 2021 - 2028

New York, Aug. 05, 2021 (GLOBE NEWSWIRE) -- announces the release of the report "Healthcare Contract Research Organization Market Size, Share & Trends Analysis Report By Type, By Service, By Region And Segment Forecasts, 2021 - 2028" -

Healthcare Contract Research Organization Market Growth & Trends

The global healthcare contract research organization market size is expected to reach USD 66.0 billion by 2028. The market is expected to expand at a CAGR of 6.6% from 2021 to 2028. The increasing cost of drug development is expected to drive market demand over the forecast period. Also, rising clinical trials cost and challenges pertaining to patient recruitment have led biopharmaceutical companies to turn to regions like Central and Eastern Europe, Asia Pacific, Latin America, and Middle East for cost savings and quick patient recruitment.

In addition, growing pressure on industry players to follow stringent timelines has increased the demand for outsourcing research activities to Contract Research Organizations (CROs). Some government organizations are also outsourcing their clinical trial activities so that they can carry out clinical trials with the required infrastructure, expertise, and minimize their cost and timelines.

However, the COVID-19 pandemic has significantly impacted the CRO market.The worldwide focus on finding a vaccine against coronavirus has had a significant impact on the development of other vaccines and drugs.

At the peak of the pandemic, vaccines and treatments for COVID-19 accounted for 30% of all the trials in the U.S. This resulted in other trials being put on hold.

The CRO market is recovering slowly through a hybrid approach.They are playing a significant role in helping sponsors and sites to start clinical trials.

Market players have already built powerful tools to support virtual clinical trials. They are ready to rapidly assist sponsors to shift to this new environment and leverage the available tools.

Healthcare Contract Research Organization Market Report Highlights
• The clinical trial services segment dominated the market in 2020 and accounted for the largest revenue share of 76.7% owing to the fact that it comprises four elaborate phases, including human subjects
• The clinical monitoring segment was the largest in terms of revenue share in 2020
• North America held a significant revenue share of 25.7% in 2020 due to the presence of several global players, who invest a major part of their revenue in research activities
• In Asia Pacific, the market is anticipated to witness a lucrative growth rate of 8.1% over the forecast period due to the reduced cost it offers in comparison to the U.S and other developed economies
• China, Japan, and India are projected to witness tremendous growth in the market owing to high disease prevalence
Read the full report:

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.


CONTACT: Clare: US: (339)-368-6001 Intl: +1 339-368-6001

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting